Latest Drug Development Pilot Awards Announced

Five projects received Drug Development Pilot Awards in the latest round:

Development of UR214-7 and UR214-9 for cancer treatments
Kyu Kwang Kim, Department of Obstetrics and Gynecology

Small Molecule Modulators of U2AF-Dependent Splicing in Myelodysplastic Syndromes
Clara L. Kielkopf, Department of Biochemistry and Biophysics

Innate Immunity guided screening for apicomplexan profilins
Felix Yarovinsky, Department of Microbiology and Immunology

Creation and development of fully-transmembrane receptor effectors
Omar Bakht and Omar Aljitawi, Department of Medicine, Hematology / Oncology

A new alarmin S100A11 in host defense and inflammation
Felix Yarovinsky, Department of Microbiology and Immunology

The Drug Development Pilot Award Program (DDPA) supports projects in drug development research that result in technology development, extramural funding, and commercialization. This program is restricted to SMD faculty and awards funds up to $10,000 or $50,000, depending upon the award type.

To learn more about the DDPA, visit: http://www.rochester.edu/ventures/for-ur-innovators/resources-innovators/drug-development-pilot-award/